Phase 3 readouts expected in 2028

Every Phase 3 and Phase 2/3 study on a drug AssetMemo covers whose estimated primary completion date falls in 2028, by month. The primary completion date is the sponsor's estimate of when the last participant is assessed for the primary endpoint, so it is the nearest public marker of a readout, not a confirmed date. Dates move: recent moves are on the delayed readouts page, and every phase is on the readout calendar.

Summary

721 studies (620 Phase 3, 101 Phase 2/3) across 453 drugs.

January 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-01 (month only)ResmetiromMadrigal PharmaceuticalsMASH / NASHPhase 3NCT03900429
2028-01 (month only)RosuvastatinAstraZeneca, ShionogiVenous Thromboembolism, Blood Clot, Post Thrombotic SyndromePhase 3NCT04319627
2028-01 (month only)Ubrogepant (Ubrelvy)AbbVieMigrainePhase 3NCT05127954
2028-01 (month only)TertomotideGemVax & KAELAlzheimer's DiseasePhase 3NCT05303701
2028-01 (month only)AzetukalnerXenon PharmaceuticalsEpilepsy, Focal Onset SeizuresPhase 3NCT05716100
2028-01 (month only)RemlifanserinAcadia PharmaceuticalsAlzheimer's Disease, Alzheimer's Disease PsychosisPhase 2/3NCT06159673
2028-01 (month only)Doravirine, Tenofovir disoproxil fumarate (Viread)Merck & Co., Gilead SciencesHIVPhase 3NCT06203132
2028-01 (month only)S-1Nordic Group B.V., Taiho PharmaceuticalPancreatic CancerPhase 3NCT06571461
2028-01 (month only)Taurolidine/heparinCorMedix, ND Partners, LLCCentral Line Associated Blood Stream Infections (CLABSI)Phase 3NCT06822426
2028-01 (month only)FelcorekibartGlaxoSmithKline, Jiangsu Hengrui PharmaceuticalsAsthmaPhase 3NCT07098403
2028-01 (month only)eloralintideEli LillyObesityPhase 3NCT07282600
2028-01 (month only)Tirzepatide (Mounjaro)Eli Lilly, Tanabe Pharma CorporationType 1 Diabetes, Type 1 Diabetes Mellitus, T1D, T1DM, T1DM - Type 1 Diabetes MellitusPhase 2/3NCT07284511
2028-01 (month only)SHR-3167Jiangsu Hengrui PharmaceuticalsType 2 DiabetesPhase 3NCT07913061
2028-01 (month only)CrinecerfontNeurocrine BiosciencesCongenital Adrenal HyperplasiaPhase 3NCT07947368
2028-01-01EmpagliflozinBoehringer Ingelheim, Eli LillyCardiotoxicityPhase 3NCT05271162
2028-01-01Methotrexate, Docetaxel, CapecitabineSanofi, Cheplapharm Arzneimittel GmbHNPC, HNSCC, Recurrence, MetastasisPhase 2/3NCT06719479
2028-01-01Denosumab (Prolia)Amgen, Daiichi SankyoSarcopenia in ElderlyPhase 3NCT07056478
2028-01-01Serplulimab, CapecitabineAbbott, Accord Healthcare, EisaiRectal Cancer, Total Neoadjuvant Therapy, Radiotherapy, ImmunotherapyPhase 3NCT07113275
2028-01-01Sutantatug envedotinCorbus Pharmaceuticals, CSPC Megalith BiopharmaceuticalCervical CancerPhase 3NCT07230626
2028-01-03maridebart cafraglutideAmgenObesityPhase 3NCT07575399
2028-01-05DepemokimabGlaxoSmithKlineAsthmaPhase 3NCT06979323
2028-01-07CemiplimabRegeneron PharmaceuticalsCutaneous Squamous Cell CarcinomaPhase 3NCT03969004
2028-01-10Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Endometrial CancerPhase 3NCT06132958
2028-01-10Pembrolizumab, Abp 234Merck & Co., AmgenNon-Small Cell Lung CancerPhase 3NCT06311721
2028-01-10AnifrolumabAstraZeneca, MedImmune LLCIdiopathic Inflammatory MyopathiesPhase 3NCT06455449
2028-01-14icotrokinraJohnson & Johnson, Protagonist TherapeuticsUlcerative ColitisPhase 3NCT07196748
2028-01-15BevacizumabRocheCerebral AV MalformationPhase 2/3NCT06264531
2028-01-15PertuzumabRocheBreast CancerPhase 2/3NCT07294508
2028-01-16Disitamab Vedotin, CapecitabinePfizer, RemeGen Co., Ltd., Cheplapharm Arzneimittel GmbHHER2-Positive Breast CancerPhase 2/3NCT07366840
2028-01-17survodutideBoehringer Ingelheim, Zealand PharmaType 2 DiabetesPhase 3NCT07754461
2028-01-21OlaparibAstraZeneca, Merck & Co.Ovarian CancerPhase 3NCT05255471
2028-01-23PonsegromabPfizerCachexia, Metastatic Pancreatic Ductal AdenocarcinomaPhase 2/3NCT06989437
2028-01-24CalderasibMerck & Co.Non-Small Cell Lung CancerPhase 3NCT06345729
2028-01-25NivolumabBristol-Myers Squibb, Ono PharmaceuticalMelanomaPhase 3NCT06054555
2028-01-25Pembrolizumab, Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT06170788
2028-01-27PF-07307405PfizerLyme DiseasePhase 3NCT07226882
2028-01-30Ifinatamab DeruxtecanDaiichi Sankyo, Merck & Co.Small Cell Lung CancerPhase 3NCT06203210
2028-01-30PovetaciceptVertex PharmaceuticalsIgA NephropathyPhase 3NCT06564142
2028-01-31TucatinibMerck & Co., PfizerHER2-Positive Breast Cancer, Breast CancerPhase 3NCT04457596
2028-01-31metforminThyroid CancerPhase 3NCT05468554
2028-01-31N-acetylcysteineApotex Inc., Phebra Pty LtdAutism Spectrum DisorderPhase 2/3NCT05664789
2028-01-31DolutegravirShionogi, ViiV HealthcareHIVPhase 3NCT06497465
2028-01-31RituximabBiogen, Chugai Pharma, RocheThrombocytopenia PurpuraPhase 3NCT07051915
2028-01-31DexamethasoneInfant, Premature, Bronchopulmonary Dysplasia (BPD)Phase 3NCT07052201
2028-01-31Notiretatug rezetecan, AdebrelimabJiangsu Hengrui PharmaceuticalsUrothelial CarcinomaPhase 3NCT07393542
2028-01-31DapagliflozinAstraZeneca, Ono PharmaceuticalHeart FailurePhase 2/3NCT07469722

February 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-02 (month only)risankizumabAbbVie, Boehringer IngelheimCrohn's DiseasePhase 3NCT04524611
2028-02 (month only)OlezarsenIonis Pharmaceuticals, Swedish Orphan Biovitrum AB (publ), TheratechnologiesFamilial Chylomicronemia SyndromePhase 3NCT05130450
2028-02 (month only)onabotulinumtoxinAAbbVieBuerger Disease, Raynaud SyndromePhase 3NCT05698979
2028-02 (month only)GivinostatItalfarmaco S.p.A., JCR PharmaceuticalsDuchenne Muscular DystrophyPhase 3NCT05933057
2028-02 (month only)Semaglutide (Ozempic)Novo NordiskAcute Ischemic Stroke, Large Vessel Occlusion, Neuroprotective Drugs, Endovascular TreatmentPhase 3NCT06788626
2028-02 (month only)vunakizumabJiangsu Hengrui PharmaceuticalsActive Non-radiographic Axial SpondyloarthritisPhase 3NCT06860750
2028-02 (month only)RituximabBiogen, Chugai Pharma, RocheGranulomatosis With Polyangiitis, Microscopic Polyangiitis (MPA)Phase 3NCT06983821
2028-02 (month only)DexamethasoneCervicobrachial NeuralgiaPhase 3NCT07084285
2028-02 (month only)lonapegsomatropinAscendis Pharma A/S, Teijin, VISEN PharmaceuticalsTurner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature, Small for Gestational Age at DeliveryPhase 3NCT07221851
2028-02 (month only)ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesityPhase 3NCT07284875
2028-02 (month only)BrenipatideEli LillyMajor Depressive DisorderPhase 3NCT07412756
2028-02 (month only)MethotrexateErosive Hand OsteoarthritisPhase 2/3NCT07501507
2028-02 (month only)lebrikizumabAlmirall, Eli LillyAtopic DermatitisPhase 3NCT07873801
2028-02-01LetrozoleNovartisOvarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, High-grade Serous Ovarian Carcinoma (HGSOC), Low-grade Serous Ovarian Carcinoma (LGSOC), Ovarian Endometrioid CarcinomaPhase 3NCT04111978
2028-02-01indacaterol maleate / mometasone furoateNovartisAsthmaPhase 3NCT05562466
2028-02-01Semaglutide (Ozempic)Novo NordiskPCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, ObesePhase 3NCT05819853
2028-02-01Rilertinib (SH-1028)Nanjing Sanhome PharmaceuticalNon-Small Cell Lung CancerPhase 3NCT06080776
2028-02-01IvosidenibServierLocally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment RegimenPhase 3NCT06127407
2028-02-01AzacitidineBristol-Myers SquibbPeripheral T Cell LymphomaPhase 2/3NCT07389616
2028-02-01Venetoclax, AzacitidineAbbVie, Roche, Bristol-Myers SquibbAcute Myeloid LeukemiaPhase 3NCT07407660
2028-02-02Datopotamab DeruxtecanAstraZeneca, Daiichi SankyoHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT07205822
2028-02-03Inclisiran, PelacarsenAlnylam Pharmaceuticals, Novartis, Ionis PharmaceuticalsAtherosclerotic Cardiovascular DiseasePhase 3NCT06813911
2028-02-04sonelokimabMoonLake ImmunotherapeuticsPsoriatic ArthritisPhase 3NCT07223138
2028-02-07tezepelumabAmgen, AstraZenecaAsthmaPhase 3NCT07363642
2028-02-09BaxdrostatAstraZeneca, RocheHypertensionPhase 3NCT07686120
2028-02-14AdebrelimabJiangsu Hengrui PharmaceuticalsOvarian Cancer RecurrentPhase 2/3NCT06791460
2028-02-14JNJ-101556143Johnson & JohnsonProstate CancerPhase 3NCT07906717
2028-02-15Osimertinib, GlumetinibAstraZeneca, Haihe Biopharma, Taiho PharmaceuticalNon-Small Cell Lung CancerPhase 3NCT06829459
2028-02-16NeratinibKnight Therapeutics, Pierre Fabre Medicament, Puma BiotechnologyHER2-Positive Breast Cancer, Breast CancerPhase 3NCT05760612
2028-02-16TrontinemabRocheAlzheimer's DiseasePhase 3NCT07169578
2028-02-16TrontinemabRocheAlzheimer's DiseasePhase 3NCT07170150
2028-02-16BerobenatidePfizerObesityPhase 3NCT07845500
2028-02-17Trastuzumab DeruxtecanAstraZeneca, Daiichi SankyoAdvanced Cancer, Metastatic CancerPhase 3NCT06174987
2028-02-20BenralizumabAstraZeneca, Kyowa Kirin, MedImmune LLCEosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)Phase 3NCT06512883
2028-02-20Camrelizumab, ApatinibElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Advenchen LaboratoriesHepatocellular CarcinomaPhase 2/3NCT06796803
2028-02-21Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabAlzheimer's DiseasePhase 3NCT06947941
2028-02-22Semaglutide (Wegovy tablets)Novo NordiskObesityPhase 3NCT07770841
2028-02-23cagrilintide/semaglutideNovo NordiskObesity, Type 2 DiabetesPhase 3NCT07564414
2028-02-24Dapagliflozin, BaxdrostatAstraZeneca, Ono Pharmaceutical, RocheChronic Kidney Disease, HypertensionPhase 3NCT06268873
2028-02-24enicepatideChugai Pharma, RocheObesity, Type 2 DiabetesPhase 3NCT07670416
2028-02-28baricitinibEli Lilly, IncyteDermatomyositisPhase 3NCT04972760
2028-02-28OveporextonTakeda Pharmaceutical CompanyNarcolepsyPhase 2/3NCT05816382
2028-02-28SYH2053CSPC Pharmaceutical GroupAtherosclerotic Cardiovascular DiseasePhase 3NCT07465263
2028-02-28remestemcel-LJCR Pharmaceuticals, MesoblastGraft-versus-Host DiseasePhase 3NCT07568535
2028-02-29OdronextamabRegeneron PharmaceuticalsFollicular LymphomaPhase 3NCT06091254
2028-02-29Raludotatug DeruxtecanDaiichi Sankyo, Merck & Co.Solid CancerPhase 2/3NCT06161025
2028-02-29GSK 5733584GlaxoSmithKlineNeoplasms, EndometrialPhase 3NCT07286331
2028-02-29ZemocimigRocheHemophilia APhase 3NCT07416604
2028-02-29CMS-D001China Medical System, Dermavon HoldingsPsoriasisPhase 2/3NCT07432854
2028-02-29UBT251Novo Nordisk, United Bio-Technology (Hengqin)Type 2 DiabetesPhase 3NCT07653477

March 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-03 (month only)adalimumab, infliximab, certolizumab pegol, tofacitinib, etanercept, Abatacept, baricitinib, Methotrexate, Rituximab, Hydroxychloroquine, SarilumabAbbVie, Johnson & Johnson, UCBRheumatoid ArthritisPhase 3NCT03414502
2028-03 (month only)MethylprednisolonePfizerMyocarditis AcutePhase 3NCT05150704
2028-03 (month only)Pembrolizumab, tebentafusp-tebnMerck & Co., Immunocore Holdings plcMelanomaPhase 3NCT05549297
2028-03 (month only)Atogepant (Qulipta)AbbVieMigrainePhase 3NCT05711394
2028-03 (month only)baricitinibEli Lilly, IncyteAlopecia AreataPhase 3NCT05723198
2028-03 (month only)Capsaicin (Qutenza)Apotex Inc., BCWorld Pharm, ClinectChemotherapy-induced Peripheral NeuropathyPhase 3NCT05840562
2028-03 (month only)AnakinraSwedish Orphan Biovitrum AB (publ)Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, Long COVIDPhase 2/3NCT05926505
2028-03 (month only)upadacitinibAbbVieVitiligoPhase 3NCT06118411
2028-03 (month only)Trastuzumab pamirtecanBioNTech, DualityBio Inc.Endometrial CancerPhase 3NCT06340568
2028-03 (month only)Venetoclax, Obinutuzumab, AcalabrutinibAbbVie, Roche, AstraZenecaChronic Lymphocytic LeukemiaPhase 3NCT06428019
2028-03 (month only)Eptinezumab (Vyepti)H. LundbeckMigrainePhase 3NCT06428838
2028-03 (month only)Lenalidomide, Rituximab, EpcoritamabBristol-Myers Squibb, Celgene Corporation, BiogenDiffuse Large B-Cell Lymphoma, Large B-Cell LymphomaPhase 3NCT06508658
2028-03 (month only)metreleptinChiesi FarmaceuticiFamilial Partial LipodystrophyPhase 3NCT06679270
2028-03 (month only)Iparomlimab and tuvonralimabQilu PharmaceuticalSmall-cell Lung CancerPhase 3NCT06789796
2028-03 (month only)Milsaperidone (VHX-896)Vanda PharmaceuticalsMajor Depressive DisorderPhase 3NCT06830044
2028-03 (month only)Carfilzomib, Pomalidomide, DexamethasoneAmgen, Ono Pharmaceutical, Bristol-Myers SquibbMultiple MyelomaPhase 2/3NCT06879379
2028-03 (month only)Adebrelimab, Trastuzumab rezetecanJiangsu Hengrui Pharmaceuticals, Glenmark Pharmaceuticals Ltd.Breast CancerPhase 3NCT07111832
2028-03 (month only)orforglipronChugai Pharma, Eli LillyObesityPhase 3NCT07202884
2028-03 (month only)ObicetrapibA. Menarini, NewAmsterdam Pharma, Tanabe Pharma CorporationType 2 DiabetesPhase 3NCT07219602
2028-03 (month only)UlotarontOtsuka HoldingsSchizophreniaPhase 3NCT07225712
2028-03 (month only)ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesityPhase 3NCT07284979
2028-03 (month only)eloralintideEli LillyObesityPhase 3NCT07321886
2028-03 (month only)eloralintideEli LillyObesity, OsteoarthritisPhase 3NCT07353931
2028-03 (month only)eloralintideEli LillyObesityPhase 3NCT07369011
2028-03 (month only)EsreboxetineAxsome Therapeutics, PfizerFibromyalgiaPhase 3NCT07398417
2028-03 (month only)RinzimetostatORIC PharmaceuticalsProstate CancerPhase 3NCT07723248
2028-03 (month only)HDM1005Hangzhou Zhongmei Huadong PharmaceuticalObesityPhase 3NCT07787260
2028-03 (month only)orforglipronChugai Pharma, Eli LillyObesityPhase 3NCT07790861
2028-03-01Ipilimumab, CabozantinibBristol-Myers Squibb, Ono Pharmaceutical, ExelixisRenal Cell Carcinoma, Clear Cell Renal Cell CarcinomaPhase 3NCT03793166
2028-03-01Pembrolizumab, lifileucelMerck & Co., Iovance BiotherapeuticsMelanomaPhase 3NCT05727904
2028-03-01Disitamab VedotinPfizer, RemeGen Co., Ltd.HR+/HER2- Metastatic Breast CancerPhase 3NCT05904964
2028-03-01tezepelumabAmgen, AstraZenecaChronic Rhinosinusitis With Nasal PolypsPhase 3NCT07520162
2028-03-01Utidelone, CapecitabineBeijing Biostar Pharmaceuticals, Cheplapharm Arzneimittel GmbHHR+/HER2- Metastatic Breast CancerPhase 3NCT07684456
2028-03-04BevacizumabRocheColorectal Cancer, Metastatic Colorectal CancerPhase 3NCT06642844
2028-03-10Fetrastobart vedotinPfizer, SeagenNon-Small Cell Lung CancerPhase 3NCT07144280
2028-03-10tilrekimigPfizerAtopic DermatitisPhase 3NCT07765888
2028-03-13PertuzumabRocheBreast CancerPhase 3NCT06876714
2028-03-13Izalontamab brengitecanBristol-Myers Squibb, Sichuan Baili PharmaceuticalBreast NeoplasmsPhase 2/3NCT06926868
2028-03-14BerobenatidePfizerObesityPhase 3NCT07792954
2028-03-15Ropeginterferon alfa-2b (Besremi)AOP Orphan Pharmaceuticals GmbH, PharmaEssentia CorporationEssential ThrombocythaemiaPhase 3NCT06514807
2028-03-15TepotinibMerck KGaANon-Small Cell Lung CancerPhase 3NCT06908993
2028-03-16MezagitamabTakeda Pharmaceutical CompanyImmune Thrombocytopenic Purpura (ITP)Phase 3NCT06722235
2028-03-19PF-06651600PfizerAlopecia AreataPhase 3NCT06873945
2028-03-21apremilastAmgenPsoriatic ArthritisPhase 3NCT04804553
2028-03-21Datopotamab DeruxtecanAstraZeneca, Daiichi SankyoNon-Small Cell Lung CancerPhase 3NCT06350097
2028-03-21InclisiranAlnylam Pharmaceuticals, NovartisAtherosclerotic Cardiovascular Disease, Homozygous Familial HypercholesterolemiaPhase 3NCT06597006
2028-03-21InclisiranAlnylam Pharmaceuticals, NovartisAtherosclerotic Cardiovascular DiseasePhase 3NCT06597019
2028-03-24FrexalimabSanofiMultiple SclerosisPhase 3NCT06141486
2028-03-24Efimosfermin alfaGlaxoSmithKlineMASH / NASHPhase 3NCT07221188
2028-03-27stapokibartAeira Pte. Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Keymed BiosciencesBullous Pemphigoid (BP)Phase 3NCT07210554
2028-03-27ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesityPhase 3NCT07284901
2028-03-29Efimosfermin alfaGlaxoSmithKlineMASH / NASHPhase 3NCT07221227
2028-03-30LetrozoleNovartisEndometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone ResistancePhase 2/3NCT05316935
2028-03-30OdronextamabRegeneron PharmaceuticalsDiffuse Large B-Cell LymphomaPhase 3NCT06091865
2028-03-30LetrozoleNovartisEndometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance, ObesityPhase 2/3NCT06379113
2028-03-30CenobamateAngelini Pharma S.p.A. (A.C.R.A.F. S.p.A.), Eurofarma Laboratorios, Hikma Pharmaceuticals PLCEpilepsyPhase 3NCT07594158
2028-03-30AMT-116Multitude Therapeutics Inc.Non-Small Cell Lung CancerPhase 2/3NCT07718737
2028-03-30ivarmacitinibJiangsu Hengrui Pharmaceuticals, Reistone BiopharmaSystemic Lupus ErthematosusPhase 2/3NCT07814664
2028-03-30ivarmacitinibJiangsu Hengrui Pharmaceuticals, Reistone BiopharmaPolymyalgia Rheumatica (PMR)Phase 2/3NCT07941778
2028-03-31Tamoxifen (Soltamox), LetrozoleMayne Pharma, Rosemont Pharmaceuticals, NovartisInfertilityPhase 3NCT03011684
2028-03-31CapecitabineCheplapharm Arzneimittel GmbHGastric CancerPhase 3NCT04248452
2028-03-31Obinutuzumab, tocilizumabRoche, Chugai PharmaDiffuse Large B-cell LymphomaPhase 3NCT04408638
2028-03-31OlpasiranAmgen, Arrowhead PharmaceuticalsAtherosclerotic Cardiovascular DiseasePhase 3NCT05581303
2028-03-31Dimethyl fumarate (Skilarence)AlmirallAdrenomyeloneuropathy Without Cerebral InvolvementPhase 2/3NCT06513533
2028-03-31VutrisiranAlnylam PharmaceuticalsTransthyretin Amyloidosis with CardiomyopathyPhase 3NCT06679946
2028-03-31nitric oxideKeenova Therapeutics, Linde HealthcareNitric Oxide, Cardiac Surgery, Cardiopulmonary Bypass, Adult Patients Undergoing Cardiovascular Surgery With Cardiopulmonary BypassPhase 3NCT06702553
2028-03-31BlinatumomabAmgenMyasthenia GravisPhase 2/3NCT06836973
2028-03-31LW402Shanghai Longwood BiopharmaceuticalsAtopic DermatitisPhase 3NCT07370909
2028-03-31Venetoclax, AzacitidineAbbVie, Roche, Bristol-Myers SquibbAcute Myeloid LeukemiaPhase 3NCT07469046

April 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-04 (month only)Lecanemab, EtalanetugBiogen, EisaiAlzheimer's DiseasePhase 2/3NCT01760005
2028-04 (month only)risankizumabAbbVie, Boehringer IngelheimPsoriasisPhase 3NCT04862286
2028-04 (month only)TeclistamabJohnson & JohnsonMultiple MyelomaPhase 3NCT05243797
2028-04 (month only)EtalanetugEisaiAlzheimer's DiseasePhase 2/3NCT05269394
2028-04 (month only)Sacituzumab GovitecanGilead SciencesHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT05840211
2028-04 (month only)PembrolizumabMerck & Co.Progressive Multifocal LeukoencephalopathyPhase 2/3NCT06276504
2028-04 (month only)ValbenazineNeurocrine Biosciences, Tanabe Pharma CorporationHuntington's DiseasePhase 3NCT06312189
2028-04 (month only)IvonescimabAkeso, Summit TherapeuticsNon-Small Cell Lung CancerPhase 3NCT06767514
2028-04 (month only)retatrutideEli LillyObesityPhase 3NCT06859268
2028-04 (month only)mirikizumab, Tirzepatide (Zepbound)Eli LillyUlcerative Colitis, ObesityPhase 3NCT06937086
2028-04 (month only)CasdatifanArcus Biosciences, Taiho PharmaceuticalClear Cell Renal Cell CarcinomaPhase 3NCT07011719
2028-04 (month only)FelcorekibartGlaxoSmithKline, Jiangsu Hengrui PharmaceuticalsChronic Rhinosinusitis With Nasal PolypsPhase 3NCT07132827
2028-04 (month only)orforglipronChugai Pharma, Eli LillyObesity, OsteoarthritisPhase 3NCT07153471
2028-04 (month only)AdebrelimabJiangsu Hengrui PharmaceuticalsAdvanced Cervical CancerPhase 3NCT07168200
2028-04 (month only)BrenipatideEli LillyAlcohol Use DisorderPhase 3NCT07219953
2028-04 (month only)BrenipatideEli LillyAlcohol Use DisorderPhase 3NCT07219966
2028-04 (month only)MethylprednisolonePfizerHand OsteoarthritisPhase 3NCT07371572
2028-04 (month only)QLC7401Qilu Pharmaceutical, Suzhou Ribo Life ScienceAtherosclerotic Cardiovascular DiseasePhase 3NCT07450378
2028-04 (month only)TARA-002Chugai Pharma, Protara TherapeuticsNon-Muscle Invasive Bladder CancerPhase 3NCT07480356
2028-04 (month only)Nab-paclitaxel, DaraxonrasibBristol-Myers Squibb, BeOne Medicines, Revolution MedicinesPancreatic Ductal AdenocarcinomaPhase 3NCT07491445
2028-04 (month only)TicagrelorAstraZenecaAtherosclerotic Cardiovascular DiseasePhase 3NCT07582835
2028-04 (month only)sildenafilPfizer, ViatrisPulmonary Arterial HypertensionPhase 2/3NCT07824674
2028-04-01Atezolizumab, BevacizumabChugai Pharma, RocheColorectal Cancer, Metastatic Colorectal CancerPhase 3NCT06733038
2028-04-01TislelizumabBeOne MedicinesGastric CancerPhase 3NCT06793917
2028-04-01ObinutuzumabRocheMembranous Nephropathy - PLA2R InducedPhase 2/3NCT07163611
2028-04-05HSK44459Haisco Pharmaceutical GroupIdiopathic Pulmonary FibrosisPhase 3NCT07519070
2028-04-06TAR-210Johnson & JohnsonNon-Muscle Invasive Bladder CancerPhase 3NCT06919965
2028-04-06elecoglipronAstraZeneca, EccogeneObesity, Type 2 DiabetesPhase 3NCT07775404
2028-04-10Sotiburafusp alfaHuabo Biopharm Co.Non-Small Cell Lung CancerPhase 3NCT07360132
2028-04-10Sotiburafusp alfa, pemetrexedHuabo Biopharm Co., Eli LillyNon-Small Cell Lung CancerPhase 3NCT07383116
2028-04-12bimekizumabUCBPsoriatic ArthritisPhase 3NCT06668181
2028-04-14Atrasentan, ZigakibartNovartisIgA Nephropathy, Chronic Kidney DiseasePhase 3NCT04573478
2028-04-15AcoramidisAlexion Pharmaceuticals, Inc. (subsidiary of AstraZeneca), Bayer, BridgeBio PharmaAmyloid Cardiomyopathy, Transthyretin-RelatedPhase 3NCT04988386
2028-04-18DuloxetineEli LillyER+ Breast Cancer, HER2-negative Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Drug-Related Side Effects and Adverse Reactions, Musculoskeletal PainPhase 3NCT06407401
2028-04-19Amdokitug (Yisaituo)Sunshine Guojian PharmaceuticalAxial Spondyloarthritis, Non-RadiographicPhase 3NCT07349329
2028-04-20Abemaciclib, Ribociclib, Palbociclib, GiredestrantEli Lilly, Novartis, PfizerHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06065748
2028-04-24PioglitazoneTakeda Pharmaceutical CompanyANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic GlomerulonephritisPhase 3NCT05946564
2028-04-24Rituximab, GolcadomideBiogen, Chugai Pharma, RocheFollicular LymphomaPhase 3NCT06911502
2028-04-26PF-06651600PfizerAlopecia AreataPhase 3NCT07733765
2028-04-27Roflumilast (Zoryve)Arcutis Biotherapeutics, Huadong Medicine, Sato Pharmaceutical Co., Ltd.Atopic DermatitisPhase 3NCT07916480
2028-04-28Zanidatamab, Eribulin mesylate, CapecitabineBeOne Medicines, Jazz Pharmaceuticals, ZymeworksHER2-Positive Breast Cancer, Breast CancerPhase 3NCT06435429
2028-04-28PertuzumabRocheHER2-Positive Breast Cancer, Breast CancerPhase 3NCT07377643
2028-04-30Eptinezumab (Vyepti)H. LundbeckMigrainePhase 3NCT05164172
2028-04-30BefotertinibBetta Pharmaceuticals Co., InventisBioNon-Small Cell Lung CancerPhase 3NCT06041776
2028-04-30vedolizumab, infliximabTakeda Pharmaceutical Company, Johnson & JohnsonUlcerative ColitisPhase 3NCT06614387
2028-04-30Fulvestrant, ZovegalisibAstraZeneca, Relay Therapeutics, Inc.HR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06982521
2028-04-30Clemidsogene lanparvovecNippon Shinyaku, REGENXBIO Inc.Mucopolysaccharidosis Type IIPhase 3NCT07236606
2028-04-30TislelizumabBeOne MedicinesNasopharyngeal CarcinomaPhase 3NCT07373990
2028-04-30Tambotatug pelitecanMediLink Therapeutics (Suzhou) Co., Ltd., RocheEsophageal Squamous Cell CarcinomaPhase 3NCT07487896
2028-04-30BerobenatidePfizerObesityPhase 3NCT07823608

May 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-05 (month only)Venetoclax, Obinutuzumab, AcalabrutinibAbbVie, Roche, AstraZenecaChronic Lymphocytic LeukemiaPhase 3NCT05197192
2028-05 (month only)DonanemabEli LillyAlzheimer's DiseasePhase 3NCT05508789
2028-05 (month only)OcrelizumabRocheMultiple SclerosisPhase 3NCT05999604
2028-05 (month only)mirikizumab, Tirzepatide (Zepbound)Eli LillyCrohn's Disease, ObesityPhase 3NCT06937099
2028-05 (month only)Delpacibart braxlosiranNovartisFacioscapulohumeral Muscular DystrophyPhase 3NCT07038200
2028-05 (month only)Cannabidiol (Epidiolex)GW Pharmaceuticals, Jazz PharmaceuticalsOpioid Use DisorderPhase 3NCT07148206
2028-05 (month only)GemcitabineEli LillyNon Muscle Invasive Bladder CancerPhase 2/3NCT07198451
2028-05 (month only)LenalidomideBristol-Myers Squibb, Celgene CorporationFollicular LymphomaPhase 3NCT07562022
2028-05 (month only)EsreboxetineAxsome Therapeutics, PfizerFibromyalgiaPhase 3NCT07637162
2028-05 (month only)MufemilastTianjin Hemay PharmaceuticalUlcerative ColitisPhase 3NCT07650942
2028-05 (month only)rezpegaldesleukinNektar TherapeuticsAtopic DermatitisPhase 3NCT07690371
2028-05 (month only)ObudanersenIonis PharmaceuticalsAngelman SyndromePhase 3NCT07782827
2028-05-01OSE2101OSE ImmunotherapeuticsNon-Small Cell Lung CancerPhase 3NCT06472245
2028-05-01VT3989Vivace Therapeutics, IncPleural Mesothelioma, MesotheliomaPhase 3NCT07824986
2028-05-02dupilumab, Pembrolizumab berahyaluronidase alfaRegeneron Pharmaceuticals, Sanofi, Merck & Co.Atopic DermatitisPhase 3NCT07919899
2028-05-04BerobenatidePfizerObesityPhase 3NCT07595549
2028-05-06PyrotinibDr. Reddy's Laboratories, HLB Life Science, Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 3NCT05841381
2028-05-07Ibrutinib, Venetoclax, ObinutuzumabAbbVie, Johnson & Johnson, RocheChronic Lymphocytic LeukemiaPhase 3NCT03701282
2028-05-08secukinumabNovartisPolymyalgia RheumaticaPhase 3NCT06331312
2028-05-09duvakitugSanofi, Teva Pharmaceutical IndustriesUlcerative ColitisPhase 3NCT07184996
2028-05-10Dexamethasone, OpevesostatMerck & Co.Metastatic Castration-Resistant Prostate CancerPhase 3NCT06136650
2028-05-15AnakinraSwedish Orphan Biovitrum AB (publ)Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)Phase 2/3NCT05267821
2028-05-15Balstilimab, BotensilimabAgenus Inc., Zydus LifesciencesGastric Cancer, MSI-H, Metastatic Cancer, Advanced CancerPhase 3NCT06346197
2028-05-15Tislelizumab, Disitamab Vedotin, CapecitabineBeOne Medicines, Pfizer, RemeGen Co., Ltd.Gastric CarcinomaPhase 3NCT06944496
2028-05-15secukinumabNovartisMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Phase 3NCT07917247
2028-05-16TAK-881Takeda Pharmaceutical CompanyPrimary ImmunodeficiencyPhase 3NCT06076642
2028-05-16vedolizumabTakeda Pharmaceutical CompanyUlcerative Colitis, Crohn's DiseasePhase 3NCT06100289
2028-05-19mibavademabRegeneron PharmaceuticalsGeneralized LipodystrophyPhase 3NCT07220785
2028-05-22VicadrostatBoehringer IngelheimHeart FailurePhase 3NCT06424288
2028-05-23elecoglipronAstraZeneca, EccogeneType 2 DiabetesPhase 3NCT07662213
2028-05-23elecoglipronAstraZeneca, EccogeneType 2 DiabetesPhase 3NCT07664553
2028-05-24remibrutinib, OmalizumabNovartis, RocheChronic Spontaneous UrticariaPhase 3NCT07816328
2028-05-25SefaxersenIonis Pharmaceuticals, RocheIgA NephropathyPhase 3NCT05797610
2028-05-25LisaftoclaxAscentage Pharma Group Inc.Acute Myeloid LeukemiaPhase 3NCT06389292
2028-05-29OdronextamabRegeneron PharmaceuticalsB-Cell Non-Hodgkin LymphomaPhase 3NCT06230224
2028-05-30SavolitinibAstraZeneca, HUTCHMEDNon-Small Cell Lung CancerPhase 3NCT05009836
2028-05-30VelzatinibGlaxoSmithKlineGastrointestinal Stromal TumorPhase 3NCT07218926
2028-05-30VC005Hangzhou Zhongmei Huadong Pharmaceutical, Jiangsu Vcare PharmatechAtopic DermatitisPhase 3NCT07592585
2028-05-31Abemaciclib, Tamoxifen (Soltamox), Anastrozole, Letrozole, Exemestane, FluzoparibEli Lilly, Mayne Pharma, Rosemont PharmaceuticalsBreast CancerPhase 3NCT05891093
2028-05-31Alpelisib (BYL719)NovartisLymphatic MalformationsPhase 2/3NCT05948943
2028-05-31tezepelumabAmgen, AstraZenecaAsthmaPhase 3NCT06023589
2028-05-31Nab-paclitaxel, CamrelizumabBristol-Myers Squibb, Elevar Therapeutics, Inc., Jiangsu Hengrui PharmaceuticalsMetastatic Pancreatic CancerPhase 2/3NCT06361888
2028-05-31Sintilimab, Bevacizumab, ChidamideInnovent Biologics, Roche, Chipscreen BiosciencesColorectal CancerPhase 3NCT06497985
2028-05-31ObinutuzumabRochePrimary Membranous NephropathyPhase 3NCT06781944
2028-05-31AxatilimabIncyte, SyndaxChronic Graft-versus-Host DiseasePhase 3NCT06821542
2028-05-31rilzabrutinibSanofiAutoimmune Haemolytic AnaemiaPhase 3NCT07086976
2028-05-31Toripalimab, CapecitabineCoherus BioSciences, Inc., Shanghai Junshi Bioscience, Cheplapharm Arzneimittel GmbHEsophageal Cancer, ChemoradiotherapyPhase 3NCT07177794
2028-05-31IvonescimabAkeso, Summit TherapeuticsMetastatic Colorectal CancerPhase 3NCT07228832
2028-05-31VormatriginePraxis Precision Medicines, Inc.Epilepsy, Focal Onset SeizuresPhase 3NCT07287163
2028-05-31GilteritinibAstellas PharmaAcute Myeloid LeukemiaPhase 3NCT07463651
2028-05-31Extended-release tacrolimus (VI-0106)VIVUSPulmonary Arterial HypertensionPhase 3NCT07612657
2028-05-31ecnoglutidePfizer, Sciwind BiosciencesObesity, OsteoarthritisPhase 3NCT07734311
2028-05-31Tirzepatide (Mounjaro)Eli Lilly, Tanabe Pharma CorporationAcute Ischemic Stroke (AIS)Phase 2/3NCT07734792
2028-05-31afimkibartPfizer, RocheUlcerative ColitisPhase 3NCT07846683

June 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-06 (month only)valproateAbbVie, SanofiChildhood EpendymomaPhase 2/3NCT02265770
2028-06 (month only)apremilast, baricitinib, Anakinra, Hydroxychloroquine, Sarilumab, tocilizumab, DexamethasoneAmgen, Eli Lilly, IncyteCOVID-19Phase 3NCT02735707
2028-06 (month only)Bortezomib, Lenalidomide, Isatuximab, DexamethasoneJanssen, Takeda Pharmaceutical Company, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT03617731
2028-06 (month only)Regorafenib, AZD1390, Pegargiminase, TroriluzoleBayer, AstraZeneca, Polaris GroupGlioblastomaPhase 2/3NCT03970447
2028-06 (month only)tocilizumabChugai Pharma, RocheAntibody-mediated RejectionPhase 3NCT04561986
2028-06 (month only)AbemaciclibEli LillyBreast CancerPhase 3NCT04565054
2028-06 (month only)Methotrexate, RituximabBiogen, Chugai Pharma, RochePrimary Central Nervous System LymphomaPhase 3NCT04931368
2028-06 (month only)Venetoclax, AzacitidineAbbVie, Roche, Bristol-Myers SquibbAcute Myeloid LeukemiaPhase 2/3NCT05404906
2028-06 (month only)Nab-paclitaxel, pemetrexedBristol-Myers Squibb, Eli LillyNon-Small Cell Lung CancerPhase 3NCT05502237
2028-06 (month only)DordaviproneJazz PharmaceuticalsGliomaPhase 3NCT05580562
2028-06 (month only)BitopertinDisc Medicine, RocheErythropoietic ProtoporphyriaPhase 2/3NCT05883748
2028-06 (month only)Quetiapine (Seroquel)Cheplapharm Arzneimittel GmbH, Luye Pharma GroupMild Traumatic Brain InjuryPhase 3NCT06333990
2028-06 (month only)RituximabBiogen, Chugai Pharma, RocheOcular Myasthenia GravisPhase 3NCT06342544
2028-06 (month only)filgotinibAlfasigma, Gilead SciencesUlcerative ColitisPhase 3NCT06865417
2028-06 (month only)Semaglutide (Wegovy)Novo NordiskObesityPhase 3NCT06909006
2028-06 (month only)AzetukalnerXenon PharmaceuticalsBipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II DisorderPhase 3NCT07172516
2028-06 (month only)orforglipronChugai Pharma, Eli LillyAtherosclerotic Cardiovascular DiseasePhase 3NCT07223593
2028-06 (month only)barzolvolimabCelldex TherapeuticsChronic Inducible UrticariaPhase 3NCT07266402
2028-06 (month only)hepalatideShanghai HEP PharmaceuticalHepatitis D, ChronicPhase 3NCT07309380
2028-06 (month only)eloralintideEli LillyObesityPhase 3NCT07392190
2028-06 (month only)Rifaximin (Xifaxan)Alfasigma, Bausch HealthBloating, Rifaximin, Functional Bowel Disorder, Irritable Bowel Syndrome, Constipation, Microbiota, Metabolomic ProfilePhase 3NCT07522255
2028-06 (month only)AtebimetinibImmuneering CorporationPancreatic CancerPhase 3NCT07562152
2028-06 (month only)Surabgene lomparvovecAbbVie, REGENXBIO Inc.Diabetic RetinopathyPhase 2/3NCT07592273
2028-06 (month only)LisaftoclaxAscentage Pharma Group Inc.Acute Myeloid LeukemiaPhase 2/3NCT07597941
2028-06 (month only)LumateperoneIntra-Cellular Therapies, Johnson & JohnsonMajor Depressive DisorderPhase 3NCT07623135
2028-06 (month only)Eptinezumab (Vyepti)H. LundbeckIdiopathic Intracranial Hypertension (IIH)Phase 3NCT07645833
2028-06 (month only)Nalbuphine ERTrevi Therapeutics, Inc.Chronic Cough in Idiopathic Pulmonary FibrosisPhase 3NCT07671911
2028-06 (month only)ElismetrepTriGemX BioMigrainePhase 3NCT07674654
2028-06 (month only)rezpegaldesleukinNektar TherapeuticsAtopic DermatitisPhase 3NCT07711418
2028-06-01Ifinatamab DeruxtecanDaiichi Sankyo, Merck & Co.Esophageal Squamous Cell CarcinomaPhase 3NCT06644781
2028-06-01Pembrolizumab, Trastuzumab DeruxtecanMerck & Co., AstraZeneca, Daiichi SankyoGastric CancerPhase 3NCT06731478
2028-06-01SintilimabInnovent BiologicsEsophageal CancerPhase 3NCT07306663
2028-06-01RosuvastatinAstraZeneca, ShionogiAtherosclerotic Cardiovascular Disease, HypertriglyceridemiaPhase 3NCT07474649
2028-06-01TretinoinCheplapharm Arzneimittel GmbHHemophagocytic Lymphohistiocytosis (HLH)Phase 2/3NCT07626398
2028-06-01Docetaxel (HB1801), DocetaxelCSPC ZhongQi Pharmaceutical Technology Co., Ltd., SanofiHR+/HER2- Metastatic Breast CancerPhase 3NCT07805135
2028-06-01BerobenatidePfizerObesityPhase 3NCT07881757
2028-06-01cagrilintide/semaglutideNovo NordiskObesityPhase 3NCT07919405
2028-06-01ChidamideChipscreen Biosciences, GNT Biotech & Medicals, HUYABIO International, LLC.Colorectal CancerPhase 2/3NCT07927049
2028-06-01ChidamideChipscreen Biosciences, GNT Biotech & Medicals, HUYABIO International, LLC.Colorectal CancerPhase 2/3NCT07927075
2028-06-02InaxaplinVertex PharmaceuticalsChronic Kidney Disease, APOL1-Mediated Kidney DiseasePhase 2/3NCT05312879
2028-06-05Ruxolitinib (Opzelura)Incyte, MaruhoVitiligoPhase 3NCT06548360
2028-06-05GemcitabineEli LillyRecurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8Phase 3NCT07000084
2028-06-05zenagamtideNovo NordiskType 2 DiabetesPhase 3NCT07931495
2028-06-06DeupsilocinHelus PharmaMajor Depressive DisorderPhase 3NCT06605105
2028-06-06zenagamtideNovo NordiskObesityPhase 3NCT07503210
2028-06-06BerobenatidePfizerObesityPhase 3NCT07874633
2028-06-08CapecitabineCheplapharm Arzneimittel GmbHHER2-positive Breast CancerPhase 3NCT06992882
2028-06-08ecnoglutidePfizer, Sciwind BiosciencesObesityPhase 3NCT07836270
2028-06-09IncobotulinumtoxinA (Xeomin)Merz PharmaceuticalsPrimary Dysmenorrhea, Chronic Pelvic PainPhase 3NCT06995287
2028-06-12Rilvegostomig, Trastuzumab DeruxtecanAstraZeneca, COMPUGEN LTD, Daiichi SankyoBiliary Tract CancerPhase 3NCT06467357
2028-06-12JNJ-78934804Johnson & JohnsonCrohn's DiseasePhase 3NCT07577843
2028-06-13Xanomeline/trospium chloride, Lamotrigine, valproateBristol-Myers Squibb, Zai Lab, GlaxoSmithKlineBipolar DisorderPhase 3NCT06929273
2028-06-13sonelokimabMoonLake ImmunotherapeuticsHidradenitis SuppurativaPhase 3NCT07007637
2028-06-14AZD0120AstraZenecaMultiple MyelomaPhase 3NCT07391657
2028-06-15Pertuzumab, Docetaxel, GiredestrantRoche, SanofiBreast CancerPhase 3NCT05296798
2028-06-15Sacituzumab TirumotecanMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Cervical CancerPhase 3NCT06459180
2028-06-15OlpasiranAmgen, Arrowhead PharmaceuticalsAtherosclerotic Cardiovascular DiseasePhase 3NCT07293260
2028-06-19dupilumabRegeneron Pharmaceuticals, SanofiEosinophilic EsophagitisPhase 3NCT07112378
2028-06-19ecnoglutidePfizer, Sciwind BiosciencesObesityPhase 3NCT07434050
2028-06-20risankizumabAbbVie, Boehringer IngelheimUlcerative Colitis, Crohn's DiseasePhase 3NCT07177118
2028-06-22QiShenYiQiTasly Pharmaceutical GroupHeart FailurePhase 3NCT07687186
2028-06-23Risdiplam (Evrysdi)Genentech (Roche Group), RocheSpinal Muscular AtrophyPhase 3NCT07444476
2028-06-25TAK-881Takeda Pharmaceutical CompanyChronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Phase 3NCT06747351
2028-06-26Ifinatamab DeruxtecanDaiichi Sankyo, Merck & Co.Prostate Cancer, Prostatic NeoplasmsPhase 3NCT06925737
2028-06-26zenagamtideNovo NordiskObesityPhase 3NCT07571109
2028-06-27225Ac-PSMA-617NovartisProstate CancerPhase 2/3NCT06780670
2028-06-27zenagamtideNovo NordiskObesityPhase 3NCT07720271
2028-06-28TAR-210Johnson & JohnsonNon-Muscle Invasive Bladder NeoplasmsPhase 3NCT06319820
2028-06-28rilzabrutinibSanofiImmunoglobulin G4 Related DiseasePhase 3NCT07190196
2028-06-30Docetaxel, CapecitabineSanofi, Cheplapharm Arzneimittel GmbHGastric CancerPhase 3NCT01935778
2028-06-30DocetaxelSanofiNasopharyngeal CarcinomaPhase 3NCT04437329
2028-06-30Cetuximab, NBTXR3Eli Lilly, Merck KGaA, Johnson & JohnsonCarcinoma, Squamous CellPhase 3NCT04892173
2028-06-30RituximabBiogen, Chugai Pharma, RocheGlomerulonephritis, Membranous, Nephrotic Syndrome,IdiopathicPhase 3NCT05914155
2028-06-30valproate, Quetiapine (Seroquel)AbbVie, Sanofi, Cheplapharm Arzneimittel GmbHBipolar DepressionPhase 3NCT05973786
2028-06-30Toripalimab, GemcitabineCoherus BioSciences, Inc., Shanghai Junshi Bioscience, Eli LillyNasopharyngeal CarcinomaPhase 3NCT06228079
2028-06-30DostarlimabGlaxoSmithKlineNeoplasms, Head and NeckPhase 3NCT06256588
2028-06-30AndamertinibAvistone BiotechnologyNon-Small Cell Lung CancerPhase 3NCT06281964
2028-06-30Pegozafermin89bio, RocheMASH / NASHPhase 3NCT06419374
2028-06-30Pembrolizumab, DocetaxelMerck & Co., SanofiNon-Muscle Invasive Bladder CancerPhase 3NCT06545955
2028-06-30DapagliflozinAstraZeneca, Ono PharmaceuticalCOVID - 19, Long COVID Syndrome, SARS CoV-2Phase 3NCT06907251
2028-06-30maridebart cafraglutideAmgenObesity, Atherosclerotic Cardiovascular DiseasePhase 3NCT07037433
2028-06-30maridebart cafraglutideAmgenObesity, Heart FailurePhase 3NCT07037459
2028-06-30Nab-paclitaxel, PertuzumabBristol-Myers Squibb, RocheBreast CancerPhase 3NCT07057427
2028-06-30Huaier GranuleQidong Gaitianli Medicines Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT07197853
2028-06-30LevosimendanOrion Corporation, Tenax TherapeuticsPulmonary Hypertension due to Left Heart DiseasePhase 3NCT07288398
2028-06-30ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceMetastatic Pancreatic Ductal AdenocarcinomaPhase 3NCT07445295
2028-06-30MethylprednisolonePfizerBrain Metastases From Solid TumorsPhase 2/3NCT07542288
2028-06-30BaxdrostatAstraZeneca, RocheCardiac RemodelingPhase 3NCT07655362
2028-06-30SolriamfetolAxsome Therapeutics, Pharmanovia, SK Biopharmaceuticals Co., Ltd.Attention Deficit Hyperactivity DisorderPhase 3NCT07717879
2028-06-30SolriamfetolAxsome Therapeutics, Pharmanovia, SK Biopharmaceuticals Co., Ltd.Attention Deficit Hyperactivity DisorderPhase 3NCT07717892
2028-06-30Pyrotinib, Pertuzumab, DocetaxelDr. Reddy's Laboratories, HLB Life Science, Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 3NCT07797218

July 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-07 (month only)RituximabBiogen, Chugai Pharma, RocheFollicular LymphomaPhase 3NCT05058404
2028-07 (month only)Obinutuzumab, zanubrutinibRoche, BeOne MedicinesFollicular LymphomaPhase 3NCT05100862
2028-07 (month only)Sacituzumab GovitecanGilead SciencesBreast CancerPhase 3NCT05382299
2028-07 (month only)AL8326Advenchen LaboratoriesSmall Cell Lung CancerPhase 3NCT06247605
2028-07 (month only)Anitocabtagene autoleucelGilead SciencesMultiple MyelomaPhase 3NCT06413498
2028-07 (month only)PlozasiranArrowhead Pharmaceuticals, SanofiHypertriglyceridemiaPhase 3NCT06822790
2028-07 (month only)BevacizumabRocheRadiation Necrosis, High Grade Glioma (III or IV), Brain Metastasases, Radiation Toxicity, Radiation Effect, Radiation Injury, Radiation InjuriesPhase 3NCT06888817
2028-07 (month only)Iparomlimab and tuvonralimabQilu PharmaceuticalMetastatic Colorectal CancerPhase 3NCT07025239
2028-07 (month only)OsavampatorNeurocrine Biosciences, Takeda Pharmaceutical CompanyMajor Depressive DisorderPhase 3NCT07196501
2028-07 (month only)baricitinibEli Lilly, IncyteDiabetes Mellitus, Type 1Phase 3NCT07222332
2028-07 (month only)SHR-1918Jiangsu Hengrui PharmaceuticalsHypercholesterolemiaPhase 2/3NCT07404553
2028-07 (month only)SaroglitazarZydus LifesciencesPrimary Biliary CholangitisPhase 3NCT07424677
2028-07 (month only)ZodasiranArrowhead PharmaceuticalsHomozygous Familial HypercholesterolemiaPhase 3NCT07473843
2028-07 (month only)Daratumumab, TorutamigJohnson & Johnson, BiocadMultiple MyelomaPhase 3NCT07742215
2028-07 (month only)ASC30Ascletis PharmaObesity, Type 2 DiabetesPhase 3NCT07743450
2028-07 (month only)ASC30Ascletis PharmaObesityPhase 3NCT07743463
2028-07 (month only)VK2735Viking TherapeuticsObesityPhase 3NCT07868835
2028-07 (month only)Pembrolizumab, pemetrexedMerck & Co., Eli LillyNon-Small Cell Lung CancerPhase 3NCT07915037
2028-07-01Methotrexate, Blinatumomab, Dexamethasone, PonatinibAmgen, Incyte, Otsuka HoldingsAcute Lymphoblastic LeukemiaPhase 3NCT04530565
2028-07-01GemcitabineEli LillyStage II Gallbladder Cancer AJCC v8, Stage IIA Gallbladder Cancer AJCC v8, Stage IIB Gallbladder Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8, Stage IIIA Gallbladder Cancer AJCC v8, Stage IIIB Gallbladder Cancer AJCC v8Phase 2/3NCT04559139
2028-07-01Pembrolizumab, BevacizumabMerck & Co., RocheEndometrial CancerPhase 3NCT07198074
2028-07-01Disitamab Vedotin, GemcitabinePfizer, RemeGen Co., Ltd., Eli LillyMIBCPhase 3NCT07693959
2028-07-03Atezolizumab, tocilizumab, ObrixtamigChugai Pharma, Roche, Boehringer IngelheimAdvanced CancerPhase 3NCT07929051
2028-07-04zenagamtideNovo NordiskType 2 DiabetesPhase 3NCT07931573
2028-07-05Atezolizumab, Bevacizumab, Alectinib, Cabozantinib, Niraparib, Rucaparib, Venetoclax, Cobimetinib, pemetrexed, VemurafenibChugai Pharma, Roche, ExelixisCancerPhase 3NCT03768063
2028-07-05Capsaicin (Qutenza)Apotex Inc., BCWorld Pharm, ClinectNeuropathic Pain, Chronic PainPhase 3NCT05997979
2028-07-05elecoglipronAstraZeneca, EccogeneType 2 DiabetesPhase 3NCT07662109
2028-07-08RituximabBiogen, Chugai Pharma, RocheInterstitial Lung Disease With Systemic SclerosisPhase 3NCT06549231
2028-07-12zenagamtideNovo NordiskObesityPhase 3NCT07571005
2028-07-13elecoglipronAstraZeneca, EccogeneType 2 Diabetes, Chronic Kidney DiseasePhase 3NCT07662135
2028-07-14Bortezomib, Methotrexate, Blinatumomab, DexamethasoneJanssen, Takeda Pharmaceutical Company, AmgenAcute Lymphoblastic LeukemiaPhase 3NCT03643276
2028-07-14elecoglipron, DapagliflozinAstraZeneca, Eccogene, Ono PharmaceuticalType 2 DiabetesPhase 3NCT07662044
2028-07-18CadonilimabAkesoLocally Advanced Cervical CarcinomaPhase 3NCT07400536
2028-07-20LenalidomideBristol-Myers Squibb, Celgene CorporationIgG4 Related DiseasePhase 2/3NCT07068165
2028-07-20VenetoclaxAbbVie, RocheAcute Myeloid LeukemiaPhase 3NCT07735117
2028-07-21IptacopanNovartisAtypical Hemolytic Uremic SyndromePhase 3NCT05935215
2028-07-24enicepatideChugai Pharma, RocheObesity, Type 2 DiabetesPhase 3NCT07351045
2028-07-24zenagamtideNovo NordiskType 2 DiabetesPhase 3NCT07931599
2028-07-26survodutideBoehringer Ingelheim, Zealand PharmaObesityPhase 3NCT07850050
2028-07-31PembrolizumabMerck & Co.Non-Muscle Invasive Bladder CancerPhase 3NCT03711032
2028-07-31Azacitidine (Onureg)Bristol-Myers SquibbMyelodysplastic SyndromesPhase 2/3NCT05469737
2028-07-31SintilimabInnovent BiologicsRectal Neoplasms Malignant, RadiotherapyPhase 2/3NCT05484024
2028-07-31N-acetylcysteineApotex Inc., Phebra Pty LtdAutism Spectrum DisorderPhase 2/3NCT05494398
2028-07-31Camrelizumab, ApatinibElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Advenchen LaboratoriesHepatocellular CarcinomaPhase 3NCT06172205
2028-07-31Pozelimab, CemdisiranRegeneron Pharmaceuticals, Alnylam PharmaceuticalsAge-Related Macular DegenerationPhase 3NCT06541704
2028-07-31LerodalcibepEverest Medicines (Beijing) Co., Ltd., LIB Therapeutics, Sun Pharmaceutical IndustriesAtherosclerotic Cardiovascular DiseasePhase 3NCT07102511
2028-07-31elecoglipronAstraZeneca, EccogeneObesity, Type 2 DiabetesPhase 3NCT07667803
2028-07-31Tirzepatide (Mounjaro)Eli Lilly, Tanabe Pharma CorporationCannabis Use Disorder, Moderate, Cannabis Use Disorder, SeverePhase 3NCT07671248
2028-07-31HS-10380Hansoh Pharmaceutical GroupSchizophreniaPhase 3NCT07759869
2028-07-31zenagamtideNovo NordiskType 2 DiabetesPhase 3NCT07797335
2028-07-31RemimazolamJiangsu Hengrui PharmaceuticalsLong-term Sedation for Mechanical Ventilation, Critically Ill Intensive Care Unit PatientsPhase 3NCT07880548
2028-07-31zenagamtideNovo NordiskType 2 DiabetesPhase 3NCT07931547

August 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-08 (month only)upadacitinibAbbVieTakayasu Arteritis (TAK)Phase 3NCT04161898
2028-08 (month only)Semaglutide (Ozempic)Novo NordiskDouble DiabetesPhase 3NCT05305794
2028-08 (month only)Sacubitril/valsartanNovartis, Otsuka HoldingsHeart FailurePhase 3NCT05508035
2028-08 (month only)upadacitinibAbbVieUlcerative ColitisPhase 3NCT05782907
2028-08 (month only)upadacitinibAbbVieHidradenitis SuppurativaPhase 3NCT05889182
2028-08 (month only)ZanzalintinibExelixisHead and Neck Squamous Cell CarcinomaPhase 2/3NCT06082167
2028-08 (month only)fluticasone propionateGlaxoSmithKlineChronic Obstructive Pulmonary DiseasePhase 3NCT06234345
2028-08 (month only)BevacizumabRocheRadionecrosis of Brain, Brain MetastasesPhase 3NCT06471465
2028-08 (month only)Sacubitril/valsartanNovartis, Otsuka HoldingsCongenital Heart DiseasePhase 3NCT06693674
2028-08 (month only)DocetaxelSanofiTriple-negative Breast CancerPhase 3NCT06795503
2028-08 (month only)PonesimodLaboratoires Juvisé Pharmaceuticals, Vanda PharmaceuticalsPsoriasisPhase 3NCT07362017
2028-08 (month only)lebrikizumabAlmirall, Eli LillyNummular EczemaPhase 3NCT07542483
2028-08 (month only)PembrolizumabMerck & Co.Non-Small Cell Lung CancerPhase 3NCT07809256
2028-08-01Gabapentin, NaltrexonePfizer, ViatrisAlcohol Use DisorderPhase 3NCT05827159
2028-08-01Sacituzumab GovitecanGilead SciencesMetastatic Colorectal CancerPhase 2/3NCT06243393
2028-08-01Cannabidiol (JZP926)Jazz PharmaceuticalsEpilepsyPhase 2/3NCT07723963
2028-08-01Iparomlimab and tuvonralimabQilu PharmaceuticalMSS-type Low Rectal Cancer,Neoadjuvant Chemoradiotherapy, QL1706Phase 2/3NCT07866313
2028-08-05UliledlimabNovaBridge Biosciences, TJ Biopharma Co., Ltd.Non-Small Cell Lung CancerPhase 2/3NCT06984588
2028-08-07FinerenoneBayerChronic Kidney DiseasePhase 3NCT05457283
2028-08-07enicepatideChugai Pharma, RocheObesity, Type 2 DiabetesPhase 3NCT07351058
2028-08-07zenagamtideNovo NordiskObesity, Type 2 DiabetesPhase 3NCT07533175
2028-08-09LenbelintideAstraZenecaObesityPhase 3NCT07776509
2028-08-09LenbelintideAstraZenecaObesityPhase 3NCT07784270
2028-08-10Lenalidomide, zanubrutinibBristol-Myers Squibb, Celgene Corporation, BeOne MedicinesDiffuse Large B-Cell LymphomaPhase 3NCT06522555
2028-08-11JNJ-78934804Johnson & JohnsonUlcerative ColitisPhase 3NCT07577856
2028-08-11LenbelintideAstraZenecaObesityPhase 3NCT07784725
2028-08-13Venetoclax, RituximabAbbVie, Roche, BiogenDiffuse Large B-Cell LymphomaPhase 2/3NCT03984448
2028-08-14zenagamtideNovo NordiskObesityPhase 3NCT07481630
2028-08-14zenagamtideNovo NordiskObesityPhase 3NCT07509307
2028-08-15ChidamideChipscreen Biosciences, GNT Biotech & Medicals, HUYABIO International, LLC.T-Cell Acute Lymphoblastic Leukemia, T-Cell Lymphoblastic LymphomaPhase 3NCT07774377
2028-08-16MethylprednisolonePfizerAcute MyocarditisPhase 3NCT06522100
2028-08-17Sacituzumab Tirumotecan, DexamethasoneMerck & Co., Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT06305754
2028-08-17ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceLocally Advanced or Metastatic GC and GCJ AdenocarcinomaPhase 3NCT07362186
2028-08-18Pasritamig, JNJ-87189401Johnson & JohnsonMetastatic Castration-Resistant Prostate Cancer, Prostate CancerPhase 3NCT07164443
2028-08-20ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceNasopharyngeal CarcinomaPhase 3NCT06561763
2028-08-21bimekizumabUCBPsoriasisPhase 3NCT06425549
2028-08-21BerobenatidePfizerObesity, Type 2 DiabetesPhase 3NCT07915609
2028-08-22BerobenatidePfizerObesityPhase 3NCT07919678
2028-08-24SeltorexantJohnson & JohnsonMajor Depressive DisorderPhase 3NCT07573176
2028-08-25AnifrolumabAstraZeneca, MedImmune LLCSystemic Lupus ErythematosusPhase 3NCT07751848
2028-08-26FazirsiranArrowhead Pharmaceuticals, Takeda Pharmaceutical CompanyAlpha-1 Antitrypsin DeficiencyPhase 3NCT06165341
2028-08-30Quetiapine (Seroquel)Cheplapharm Arzneimittel GmbH, Luye Pharma GroupTreatment Resistant Depression (TRD)Phase 3NCT07760168
2028-08-30CrisugabalinHaisco Pharmaceutical GroupDiabetic Peripheral Neuropathic PainPhase 3NCT07859111
2028-08-31RituximabBiogen, Chugai Pharma, RocheRelapsed/Refractory Marginal Zone LymphomaPhase 3NCT06082102
2028-08-31Ribociclib, PalbociclibNovartis, PfizerHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06377852
2028-08-31EverolimusNovartisHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT06680921
2028-08-31SonrotoclaxBeOne MedicinesMantle Cell LymphomaPhase 3NCT06742996
2028-08-31NTQ1062Sino BiopharmaceuticalHR+/HER2- Metastatic Breast CancerPhase 3NCT07393321
2028-08-31Beruzatatug pelitecanBioNTech, MediLink Therapeutics (Suzhou) Co., Ltd.Non-Small Cell Lung CancerPhase 3NCT07416994
2028-08-31DexamethasoneKnee ArthroscopyPhase 3NCT07674576
2028-08-31Tenofovir alafenamide/emtricitabine, ACC017Gilead Sciences, Jiangsu Aidea Pharmaceutical GroupHIVPhase 3NCT07711223
2028-08-31Tabirafusp tedromerKodiak Sciences Inc.Diabetic Macular EdemaPhase 3NCT07734844

September 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-09 (month only)BevacizumabRocheColorectal Cancer, Metastatic Colorectal CancerPhase 3NCT02885753
2028-09 (month only)risankizumabAbbVie, Boehringer IngelheimUlcerative ColitisPhase 3NCT03398135
2028-09 (month only)PegargiminasePolaris GroupHepatocellular CarcinomaPhase 3NCT05317819
2028-09 (month only)DordaviproneJazz PharmaceuticalsGliomaPhase 3NCT05476939
2028-09 (month only)Osimertinib, Dacomitinib PF-00299804, AfatinibAstraZeneca, Pfizer, Boehringer IngelheimNon-Small Cell Lung CancerPhase 3NCT06486142
2028-09 (month only)Lenalidomide, TafasitamabBristol-Myers Squibb, Celgene Corporation, Beijing InnoCare Pharma Tech Co.Diffuse Large B-Cell Lymphoma, Large B-Cell LymphomaPhase 3NCT06521255
2028-09 (month only)PembrolizumabMerck & Co.Head and Neck Squamous Cell CarcinomaPhase 3NCT06699212
2028-09 (month only)Tislelizumab, Nogapendekin alfa inbakicept (Anktiva)BeOne Medicines, ImmunityBioNon-Small Cell Lung CancerPhase 3NCT06745908
2028-09 (month only)SSGJ-611Sunshine Guojian PharmaceuticalPulmonary Disease, Chronic Obstructive (COPD)Phase 3NCT07039669
2028-09 (month only)Lenacapavir (Yeztugo)Gilead SciencesHIVPhase 3NCT07047716
2028-09 (month only)Ifebemtinib, GarsorasibBoehringer Ingelheim, InxMed, InventisBioNon-Small Cell Lung CancerPhase 3NCT07174908
2028-09 (month only)barzolvolimabCelldex TherapeuticsChronic Spontaneous UrticariaPhase 3NCT07256392
2028-09 (month only)Semaglutide (Wegovy)Novo NordiskObesityPhase 3NCT07294950
2028-09 (month only)Soficitinib (ICP-332)Beijing InnoCare Pharma Tech Co.Chronic Spontaneous Urticaria (CSU)Phase 2/3NCT07378527
2028-09 (month only)Nab-paclitaxelBristol-Myers SquibbPancreatic Cancer, AdultPhase 3NCT07436741
2028-09 (month only)BHV-1400BiohavenChronic Kidney DiseasePhase 3NCT07642050
2028-09 (month only)aleniglipronStructure TherapeuticsObesityPhase 3NCT07654361
2028-09 (month only)aleniglipronStructure TherapeuticsObesity, Type 2 DiabetesPhase 3NCT07654374
2028-09 (month only)CapecitabineCheplapharm Arzneimittel GmbHGastric or Gastroesophageal Junction AdenocarcinomaPhase 3NCT07716449
2028-09 (month only)UBT251Novo Nordisk, United Bio-Technology (Hengqin)ObesityPhase 3NCT07767942
2028-09 (month only)HDM1005Hangzhou Zhongmei Huadong PharmaceuticalObesityPhase 3NCT07794397
2028-09 (month only)Entecavir (Baraclude), Tenofovir disoproxil fumarate (Viread), tenofovir alafenamide (Vemlidy), TQA3605Bristol-Myers Squibb, Gilead Sciences, Sino BiopharmaceuticalChronic Hepatitis BPhase 3NCT07797231
2028-09 (month only)REGEND001Regend TherapeuticsChronic Obstructive Pulmonary DiseasePhase 3NCT07828353
2028-09 (month only)lonapegsomatropinAscendis Pharma A/S, Teijin, VISEN PharmaceuticalsAchondroplasiaPhase 3NCT07924059
2028-09-01Camrelizumab, Apatinib, CapecitabineElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Advenchen LaboratoriesBreast CancerPhase 2/3NCT04803539
2028-09-01Furosemide (subcutaneous, SQ Innovation)SQ InnovationHeart FailurePhase 3NCT07018297
2028-09-01IvabradineAmgen, ServierCoronary Arterial Disease (CAD), Ischemic Heart Disease (IHD)Phase 2/3NCT07268170
2028-09-01ZiltivekimabNovo NordiskAtherosclerotic Cardiovascular DiseasePhase 3NCT07276282
2028-09-01DexamethasonePain, Postoperative, Liposomal Bupivacaine, Dexamethasone, Supraclavicular Brachial Plexus Block, High Risk Factors, Distal Radial FracturePhase 3NCT07665762
2028-09-01RosuvastatinAstraZeneca, ShionogiAtherosclerotic Cardiovascular DiseasePhase 3NCT07736313
2028-09-01Semaglutide (Ozempic)Novo NordiskType 1 Diabetes, Overweight , ObesityPhase 2/3NCT07891156
2028-09-01Azacitidine, SonrotoclaxBristol-Myers Squibb, BeOne MedicinesMyelodysplastic SyndromesPhase 2/3NCT07932873
2028-09-05Sigvotatug VedotinSeagenNon-Small Cell Lung CancerPhase 3NCT06758401
2028-09-06maridebart cafraglutideAmgenType 2 DiabetesPhase 3NCT07866066
2028-09-07MezagitamabTakeda Pharmaceutical CompanyChronic Kidney Disease, IgA NephropathyPhase 3NCT06963827
2028-09-08tilrekimigPfizerAtopic DermatitisPhase 3NCT07783425
2028-09-09Atezolizumab, ObrixtamigChugai Pharma, Roche, Boehringer IngelheimSmall Cell Lung CancerPhase 3NCT07472517
2028-09-11Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabAlzheimer's DiseasePhase 3NCT06976203
2028-09-11Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabAlzheimer's DiseasePhase 3NCT06976216
2028-09-12MevrometostatPfizerMetastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the ProstatePhase 3NCT07028853
2028-09-12Libevitug (HH-003)Huahui HealthChronic Hepatitis DeltaPhase 3NCT07499544
2028-09-15ElriterceptTakeda Pharmaceutical CompanyMyelodysplastic SyndromesPhase 3NCT06499285
2028-09-15INCB161734IncytePancreatic Ductal AdenocarcinomaPhase 3NCT07522073
2028-09-15CPO301Conjupro Biotherapeutics, Inc.Head and Neck Squamous Cell CarcinomaPhase 3NCT07758621
2028-09-15LenbelintideAstraZenecaObesityPhase 3NCT07922330
2028-09-17AtrasentanNovartisIgA NephropathyPhase 3NCT07850752
2028-09-19PembrolizumabMerck & Co.Colorectal CancerPhase 3NCT05239741
2028-09-19icotrokinraJohnson & Johnson, Protagonist TherapeuticsCrohn's DiseasePhase 2/3NCT07196722
2028-09-19RavulizumabAstraZenecaNMOSD, Neuromyelitis Optica Spectrum DisorderPhase 3NCT07557420
2028-09-21duvakitugSanofi, Teva Pharmaceutical IndustriesUlcerative ColitisPhase 3NCT07185009
2028-09-23Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabSchizophreniaPhase 3NCT06882785
2028-09-25SotorasibAmgenColorectal Cancer, Metastatic Colorectal Cancer, Advanced Metastatic Colorectal CancerPhase 3NCT06252649
2028-09-28BofanglutideA. Menarini, Gan & Lee Pharmaceuticals, JW PharmaceuticalObesityPhase 3NCT07501832
2028-09-29BelumosudilKadmon Corporation, Meiji Seika Pharma, SanofiGraft-versus-Host Disease, Chronic Graft-versus-Host DiseasePhase 3NCT06143891
2028-09-29225Ac-PSMA-617NovartisProstate CancerPhase 3NCT06855277
2028-09-29Torvutatug samrotecanAstraZenecaOvarian CancerPhase 3NCT07816666
2028-09-30OfatumumabNovartisMultiple SclerosisPhase 3NCT03650114
2028-09-30baricitinib, Empagliflozin, Anakinra, Hydroxychloroquine, tocilizumab, DexamethasoneEli Lilly, Incyte, Boehringer IngelheimCOVID-19Phase 3NCT04381936
2028-09-30DapagliflozinAstraZeneca, Ono PharmaceuticalHeart Transplant Failure, Kidney FailurePhase 3NCT05321706
2028-09-30CetuximabEli Lilly, Merck KGaAColorectal Cancer (CRC), Capecitabine, CetuximabPhase 3NCT06616259
2028-09-30Envafolimab3D Medicines Inc., Ascletis Pharma, Glenmark Pharmaceuticals Ltd.Metastatic Colorectal Cancer (CRC)Phase 2/3NCT06959693
2028-09-30Methotrexate, Rituximab, DexamethasoneBiogen, Chugai Pharma, RochePrimary Central Nervous System LymphomaPhase 2/3NCT07185373
2028-09-30PertuzumabRocheBreast CancerPhase 2/3NCT07294534
2028-09-30SonrotoclaxBeOne MedicinesChronic Lymphocytic LeukemiaPhase 3NCT07321652
2028-09-30Bevacizumab, Trastuzumab rezetecanRoche, Glenmark Pharmaceuticals Ltd., Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 3NCT07669610
2028-09-30N-acetylcysteineApotex Inc., Phebra Pty LtdAplastic AnemiaPhase 3NCT07737262
2028-09-30BGM0504BrightGene Bio-Medical Technology, China Resources Sanjiu Medical & PharmaceuticalObesity, Type 2 DiabetesPhase 3NCT07743983
2028-09-30Trastuzumab rezetecanGlenmark Pharmaceuticals Ltd., Jiangsu Hengrui PharmaceuticalsBreast CancerPhase 3NCT07760844
2028-09-30metformin, EmpagliflozinBoehringer Ingelheim, Eli LillyEmpgliflozin Cardioprotective EffectPhase 3NCT07815808
2028-09-30ZemocimigRocheHemophilia APhase 3NCT07838194

October 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-10 (month only)tofacitinib, tocilizumabPfizer, Chugai Pharma, RocheGranulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated VasculitisPhase 3NCT04871191
2028-10 (month only)Nab-paclitaxel, TislelizumabBristol-Myers Squibb, BeOne MedicinesHead and Neck Squamous Cell CarcinomasPhase 3NCT05582265
2028-10 (month only)pegunigalsidase alfaChiesi Farmaceutici, Protalix BioTherapeutics, Inc.Fabry DiseasePhase 2/3NCT06328608
2028-10 (month only)Adebrelimab, pemetrexedJiangsu Hengrui Pharmaceuticals, Eli LillyNon-Small Cell Lung CancerPhase 2/3NCT06335355
2028-10 (month only)SHR-1819Jiangsu Hengrui PharmaceuticalsPrurigo NodularisPhase 2/3NCT06554509
2028-10 (month only)DexamethasoneIntensive Care PediatricPhase 3NCT06722118
2028-10 (month only)Bemdaneprocel (MSK-DA01)Bayer, BlueRock TherapeuticsParkinson's DiseasePhase 3NCT06944522
2028-10 (month only)Rinatabart sesutecan (Rina-S)GenmabOvarian CancerPhase 3NCT07225270
2028-10 (month only)retatrutideEli LillyObesity, Type 2 DiabetesPhase 3NCT07357415
2028-10 (month only)TislelizumabBeOne MedicinesAdenocarcinomaPhase 3NCT07385703
2028-10 (month only)apraglutideIronwood PharmaceuticalsShort Bowel SyndromePhase 3NCT07742735
2028-10 (month only)VK2735Viking TherapeuticsObesity, Type 2 DiabetesPhase 3NCT07868939
2028-10 (month only)MesutoclaxBeijing InnoCare Pharma Tech Co.Relapsed/Refractory Marginal Zone Lymphoma (MZL)Phase 3NCT07896590
2028-10-01Venetoclax, ObinutuzumabAbbVie, RocheChronic Lymphocytic LeukemiaPhase 3NCT04269902
2028-10-01AtezolizumabChugai Pharma, RocheAdvanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma, Recurrent Extrapulmonary Neuroendocrine Carcinoma, Unresectable Extrapulmonary Neuroendocrine CarcinomaPhase 2/3NCT05058651
2028-10-01Gilteritinib, Venetoclax, AzacitidineAstellas Pharma, AbbVie, RocheAcute Myeloid LeukemiaPhase 2/3NCT07425808
2028-10-04etranacogene dezaparvovecCSL Behring, uniQureHemophilia BPhase 3NCT06003387
2028-10-05AnifrolumabAstraZeneca, MedImmune LLCSystemic Lupus ErythematosusPhase 3NCT05835310
2028-10-10Pozelimab, CemdisiranRegeneron Pharmaceuticals, Alnylam PharmaceuticalsParoxysmal Nocturnal HemoglobinuriaPhase 3NCT05744921
2028-10-10zenagamtideNovo NordiskObesityPhase 3NCT07668414
2028-10-13EnlicitideMerck & Co.Atherosclerotic Cardiovascular Disease, HypercholesterolemiaPhase 3NCT06492291
2028-10-13BerobenatidePfizerObesityPhase 3NCT07932925
2028-10-15Avutometinib/defactinib (Avmapki Fakzynja Co-Pack)Chugai Pharma, Pfizer, Verastem, Inc.Ovarian CancerPhase 3NCT06072781
2028-10-17Beclomethasone dipropionate/formoterol fumarate/glycopyrrolateChiesi FarmaceuticiAsthmaPhase 3NCT07546981
2028-10-18etanerceptAmgen, PfizerSAPHO SyndromePhase 2/3NCT06011889
2028-10-20petrelintideRoche, Zealand PharmaObesityPhase 3NCT07843485
2028-10-21Rimegepant (Nurtec ODT)Eisai, PfizerMigrainePhase 3NCT07729462
2028-10-25UlotarontOtsuka HoldingsGeneralized Anxiety DisorderPhase 3NCT07767903
2028-10-27IptacopanNovartisIC-MPGNPhase 3NCT05755386
2028-10-27FerumoxytolAzurity PharmaceuticalsGlioblastomaPhase 3NCT07461948
2028-10-30tulisokibartMerck & Co.Crohn's DiseasePhase 3NCT06430801
2028-10-30Trametinib, DabrafenibNovartisAmeloblastomaPhase 2/3NCT06819605
2028-10-30S-1Nordic Group B.V., Taiho PharmaceuticalGastric CancerPhase 3NCT07366528
2028-10-30OcankitugKeymed Biosciences, Shanghai JMT-BioChronic Rhinosinusitis With Nasal PolypsPhase 3NCT07420257
2028-10-31Osimertinib, DurvalumabAstraZenecaNon-Small Cell Lung CancerPhase 3NCT03833154
2028-10-31Ruxolitinib (Jakafi)Incyte, NovartisPolycythemia VeraPhase 3NCT04116502
2028-10-31Pembrolizumab, AdagrasibMerck & Co., Bristol-Myers Squibb, Zai LabNon-Small Cell Lung CancerPhase 2/3NCT04613596
2028-10-31EmpagliflozinBoehringer Ingelheim, Eli LillyAging, Arterial StiffnessPhase 2/3NCT06506422
2028-10-31DexamethasoneInfluenzaPhase 3NCT06528444
2028-10-31FurmonertinibAllist Pharmaceuticals, ArriVent BioPharmaNon-Small Cell Lung CancerPhase 3NCT07010419
2028-10-31Tislelizumab, pemetrexedBeOne Medicines, Eli LillyNon-Small Cell Lung CancerPhase 2/3NCT07131319
2028-10-31Bevacizumab, IBI363Roche, Innovent Biologics, Takeda Pharmaceutical CompanyColorectal CancerPhase 3NCT07722494

November 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-11 (month only)SeladelparGilead Sciences, Kaken PharmaceuticalPrimary Biliary CholangitisPhase 3NCT03301506
2028-11 (month only)LenalidomideBristol-Myers Squibb, Celgene CorporationFollicular LymphomaPhase 3NCT06284122
2028-11 (month only)Treprostinil (Remodulin)United TherapeuticsPulmonary Arterial HypertensionPhase 3NCT06350032
2028-11 (month only)EnvudeucitinibAlumis, Kaken PharmaceuticalPsoriasisPhase 3NCT06846541
2028-11 (month only)Sofetabart mipitecanEli LillyOvarian CancerPhase 3NCT07213804
2028-11 (month only)baricitinibEli Lilly, IncytePolymyalgia Rheumatica (PMR)Phase 3NCT07279688
2028-11 (month only)Semaglutide (Ozempic)Novo NordiskType 2 DiabetesPhase 3NCT07428746
2028-11 (month only)Psilocybin (COMP360)COMPASS PathwaysPost-Traumatic Stress DisorderPhase 2/3NCT07570654
2028-11 (month only)ribupatideJiangsu Hengrui Pharmaceuticals, Kailera TherapeuticsObesityPhase 3NCT07709910
2028-11 (month only)Cetuximab, GFH375Eli Lilly, Merck KGaA, GenFleet TherapeuticsMetastatic Colorectal CancerPhase 3NCT07913360
2028-11-01Trastuzumab DeruxtecanAstraZeneca, Daiichi SankyoOvarian CancerPhase 3NCT06819007
2028-11-01IBI363Innovent Biologics, Takeda Pharmaceutical CompanyNon-Small Cell Lung CancerPhase 3NCT07217301
2028-11-02Lenalidomide, AZD0120Bristol-Myers Squibb, Celgene Corporation, AstraZenecaMultiple MyelomaPhase 3NCT07735637
2028-11-03Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabAlzheimer's DiseasePhase 3NCT07011745
2028-11-06Pembrolizumab, GemcitabineMerck & Co., Eli LillyExtrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma, Distal Cholangiocarcinoma, Resectable, Borderline ResectablePhase 2/3NCT06923475
2028-11-08NivolumabBristol-Myers Squibb, Ono PharmaceuticalGastric CancerPhase 3NCT05677490
2028-11-14ZiltivekimabNovo NordiskMyocardial InfarctionPhase 3NCT07301034
2028-11-14Nintedanib (Ofev), Rituximab, tocilizumab, Zolacabtagene autoleucelBoehringer Ingelheim, Biogen, Chugai PharmaSystemic SclerosisPhase 3NCT07335562
2028-11-15risankizumab, guselkumabAbbVie, Boehringer Ingelheim, Johnson & JohnsonCrohn's DiseasePhase 3NCT07499232
2028-11-16Volrustomig, pemetrexedAstraZeneca, Eli LillyUnresectable Pleural MesotheliomaPhase 3NCT06097728
2028-11-17Torvutatug samrotecanAstraZenecaOvarian CancerPhase 3NCT07218809
2028-11-20Durvalumab, Datopotamab Deruxtecan, Olaparib, Capecitabine, EpirubicinAstraZeneca, Daiichi Sankyo, Merck & Co.Breast CancerPhase 3NCT06112379
2028-11-24Xanomeline/trospium chlorideBristol-Myers Squibb, Zai LabAlzheimer's DiseasePhase 3NCT07011732
2028-11-26ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceNasopharyngeal CarcinomaPhase 3NCT06712888
2028-11-29RavulizumabAstraZenecaIgA NephropathyPhase 3NCT07024563
2028-11-30Staccato AlprazolamNova Pneuma Inc., UCBEpilepsyPhase 3NCT05076617
2028-11-30Dexamethasone, OpevesostatMerck & Co.Prostate Cancer MetastaticPhase 3NCT06136624
2028-11-30Durvalumab, OlaparibAstraZeneca, Merck & Co.Endometrial CancerPhase 3NCT06746116
2028-11-30Pembrolizumab, DivarasibMerck & Co., RocheNon-Small Cell Lung CancerPhase 3NCT06793215
2028-11-30MethylprednisolonePfizerInfluenzaPhase 3NCT07351500
2028-11-30MethylprednisolonePfizerPsittacosisPhase 3NCT07352865
2028-11-30faricimabChugai Pharma, RocheAge-Related Macular DegenerationPhase 3NCT07461441
2028-11-30Pomalidomide, Cevostamab, DexamethasoneBristol-Myers Squibb, RocheMultiple MyelomaPhase 3NCT07555938
2028-11-30FulvestrantAstraZenecaHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT07784036
2028-11-30GiredestrantRocheEarly Breast Cancer, Estrogen Receptor-Positive Breast Cancer, HER2-Negative Breast CancerPhase 3NCT07827573

December 2028

Primary completionDrugDeveloperIndicationPhaseStudy
2028-12 (month only)VildagliptinCipla, Novartis, Sumitomo PharmadmPhase 3NCT03925701
2028-12 (month only)Telisotuzumab VedotinAbbVieNon-Small Cell Lung CancerPhase 3NCT04928846
2028-12 (month only)Vigabatrin (Sabril)H. Lundbeck, Lundbeck LLCTuberous Sclerosis ComplexPhase 2/3NCT04987463
2028-12 (month only)tildrakizumabAlmirall, China Medical System, Sun Pharmaceutical IndustriesPsoriatic ArthritisPhase 3NCT04991116
2028-12 (month only)Bevacizumab, NiraparibRoche, GlaxoSmithKline, Zai LabOvarian CancerPhase 3NCT05009082
2028-12 (month only)Trastuzumab Emtansine, CapecitabineRoche, Cheplapharm Arzneimittel GmbHBreast CancerPhase 2/3NCT05288777
2028-12 (month only)MasitinibAB ScienceAlzheimer's DiseasePhase 3NCT05564169
2028-12 (month only)SHR-1703Jiangsu Hengrui PharmaceuticalsEosinophilic Granulomatosis with PolyangiitisPhase 2/3NCT05979051
2028-12 (month only)Nab-paclitaxel, GemcitabineBristol-Myers Squibb, Eli LillyBiliary Tract Cancer, CholangiocarcinomaPhase 2/3NCT06037980
2028-12 (month only)Isatuximab, Iberdomide, DexamethasoneSanofi, Bristol-Myers SquibbMultiple MyelomaPhase 3NCT06216158
2028-12 (month only)Sotagliflozin (Inpefa)Lexicon Pharmaceuticals, ViatrisHeart Failure, Chronic Kidney Disease, Type 1 DiabetesPhase 3NCT06217302
2028-12 (month only)DexamethasoneMultiple Myeloma, Relapse Multiple MyelomaPhase 3NCT06561854
2028-12 (month only)Atezolizumab, Bevacizumab, AmezalpatChugai Pharma, Roche, Tempest TherapeuticsHepatocellular CarcinomaPhase 3NCT06680258
2028-12 (month only)Izalontamab brengitecanBristol-Myers Squibb, Sichuan Baili PharmaceuticalNon-Small Cell Lung CancerPhase 3NCT06838273
2028-12 (month only)Pertuzumab, Trastuzumab brengitecanRoche, Sichuan Baili PharmaceuticalHER2-Positive Breast Cancer, Breast CancerPhase 2/3NCT06891833
2028-12 (month only)VenetoclaxAbbVie, RocheAcute Myeloid LeukemiaPhase 3NCT07075016
2028-12 (month only)Ribociclib, PalazestrantNovartis, Olema Pharmaceuticals, Inc.HR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT07085767
2028-12 (month only)Brentuximab VedotinPfizer, Seagen, Takeda Pharmaceutical CompanyPeripheral T-Cell LymphomaPhase 3NCT07258680
2028-12 (month only)TretinoinCheplapharm Arzneimittel GmbHITP - Immune ThrombocytopeniaPhase 2/3NCT07278908
2028-12 (month only)HetrombopagJiangsu Hengrui PharmaceuticalsChemotherapy-Induced ThrombocytopeniaPhase 3NCT07286032
2028-12 (month only)BCD-281BiocadMultiple SclerosisPhase 3NCT07321093
2028-12 (month only)Dalpiciclib, HRS-8080Jiangsu Hengrui PharmaceuticalsHR+/HER2- Metastatic Breast CancerPhase 3NCT07354022
2028-12 (month only)LB-102 (methylated amisulpride)LB PharmaceuticalsSchizophreniaPhase 3NCT07369154
2028-12 (month only)TelitaciceptRemeGen Co., Ltd., Vor BioSjögren's DiseasePhase 3NCT07404865
2028-12 (month only)Obinutuzumab beta (Bejescin)Beijing Mabworks Biotech Co., Ltd., Everest Medicines (Beijing) Co., Ltd.Systemic Lupus ErythematosusPhase 3NCT07405970
2028-12 (month only)SolriamfetolAxsome Therapeutics, Pharmanovia, SK Biopharmaceuticals Co., Ltd.Major Depressive DisorderPhase 3NCT07484217
2028-12 (month only)Trastuzumab brengitecanSichuan Baili PharmaceuticalOvarian CancerPhase 3NCT07545460
2028-12 (month only)EnarodustatJW Pharmaceutical, Shenzhen Salubris Pharmaceuticals, ShionogiTransfusion-dependent Non-severe Aplastic AnemiaPhase 3NCT07548671
2028-12 (month only)Tislelizumab, Izalontamab brengitecanBeOne Medicines, Bristol-Myers Squibb, Sichuan Baili PharmaceuticalEsophageal Squamous Cell CarcinomaPhase 2/3NCT07554456
2028-12 (month only)TQB2934Sino BiopharmaceuticalMultiple MyelomaPhase 3NCT07569757
2028-12 (month only)Semaglutide (Ozempic)Novo NordiskType 2 DiabetesPhase 3NCT07581145
2028-12 (month only)Izalontamab brengitecanBristol-Myers Squibb, Sichuan Baili PharmaceuticalBiliary Tract CancerPhase 3NCT07582315
2028-12 (month only)IstaroximeLee's Pharmaceutical, Seismic PharmaHeart Failure, Cardiogenic Shock in Acute Heart FailurePhase 2/3NCT07583446
2028-12 (month only)Trastuzumab brengitecanSichuan Baili PharmaceuticalBiliary Tract CancerPhase 3NCT07606599
2028-12 (month only)Olaparib, Izalontamab brengitecanAstraZeneca, Merck & Co., Bristol-Myers SquibbMetastatic Castration-Resistant Prostate Cancer, Prostate CancerPhase 2/3NCT07641855
2028-12 (month only)Izalontamab brengitecanBristol-Myers Squibb, Sichuan Baili PharmaceuticalHR+/HER2- Metastatic Breast CancerPhase 3NCT07648914
2028-12 (month only)Human Acellular Vessel (Humacyte)HumacyteVascular TraumaPhase 3NCT07762313
2028-12 (month only)BrenipatideEli LillyMajor Depressive DisorderPhase 3NCT07775300
2028-12 (month only)pemvidutideAltimmuneMASH / NASHPhase 3NCT07795164
2028-12 (month only)JSKN033Alphamab OncologyRecurrent or Metastatic Cervical CancerPhase 3NCT07797153
2028-12 (month only)Tirzepatide (Zepbound)Eli LillyObesityPhase 3NCT07829198
2028-12 (month only)Trastuzumab brengitecanSichuan Baili PharmaceuticalUrothelial CarcinomaPhase 3NCT07869836
2028-12-01safusidenibNuvation BioGliomaPhase 3NCT05303519
2028-12-01Ferric derisomaltoseChina Medical System, Nippon Shinyaku, PfizerAnaemia in Ovarian CarcinomaPhase 3NCT06248749
2028-12-01Durvalumab, Pembrolizumab, ZanidatamabAstraZeneca, Merck & Co., BeOne MedicinesBiliary Tract CancerPhase 3NCT06282575
2028-12-01Iparomlimab and tuvonralimabQilu PharmaceuticalNasopharyngeal Cancinoma (NPC), Nasopharyngeal CancerPhase 3NCT06749899
2028-12-01Tirzepatide (Zepbound)Eli LillyObesityPhase 2/3NCT07846865
2028-12-01RC28-ERemeGen Co., Ltd., Santen Pharmaceutical Co., Ltd.Diabetic Macular EdemaPhase 3NCT07936487
2028-12-05Nerandomilast (Jascayd)Boehringer IngelheimInterstitial Lung DiseasesPhase 3NCT07540988
2028-12-06UlotarontOtsuka HoldingsGeneralized Anxiety DisorderPhase 3NCT07759128
2028-12-07SotaterceptMerck & Co.Pulmonary Arterial HypertensionPhase 3NCT07218029
2028-12-12RamantamigJohnson & JohnsonMultiple MyelomaPhase 3NCT07258511
2028-12-13DepemokimabGlaxoSmithKlineChronic Obstructive Pulmonary DiseasePhase 3NCT06959095
2028-12-13DepemokimabGlaxoSmithKlineChronic Obstructive Pulmonary DiseasePhase 3NCT06961214
2028-12-14Pyrotinib, FulvestrantDr. Reddy's Laboratories, HLB Life Science, Jiangsu Hengrui PharmaceuticalsHR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT04646759
2028-12-15Lenalidomide, RituximabBristol-Myers Squibb, Celgene Corporation, BiogenDiffuse Large B-Cell LymphomaPhase 3NCT06220032
2028-12-15AmivantamabGenmab, Johnson & JohnsonColorectal CancerPhase 3NCT06662786
2028-12-15Izalontamab brengitecanBristol-Myers Squibb, Sichuan Baili PharmaceuticalNon-Small Cell Lung CancerPhase 2/3NCT07100080
2028-12-19zenagamtideNovo NordiskObesity, Type 2 DiabetesPhase 3NCT07400107
2028-12-19olatorepatideHansoh Pharmaceutical Group, Regeneron PharmaceuticalsObesityPhase 3NCT07896265
2028-12-21LecanemabBiogen, EisaiAlzheimer's DiseasePhase 3NCT04468659
2028-12-21dupilumabRegeneron Pharmaceuticals, SanofiAsthmaPhase 3NCT06191315
2028-12-21petrelintideRoche, Zealand PharmaObesityPhase 3NCT07843498
2028-12-27ApecotrepBoehringer IngelheimChronic Kidney Disease, Focal Segmental GlomerulosclerosisPhase 3NCT07220083
2028-12-27EsketamineJohnson & JohnsonMajor Depressive DisorderPhase 3NCT07716098
2028-12-28TolvaptanOtsuka HoldingsAutosomal Recessive Polycystic Kidney (ARPKD)Phase 3NCT04782258
2028-12-29SerplulimabAbbott, Accord Healthcare, EisaiLocally Advanced Low Rectal Adenocarcinoma, pMMR (Microsatellite Stable Rectal Cancer)Phase 3NCT07277842
2028-12-29INCA33890IncyteColorectal CancerPhase 3NCT07284849
2028-12-29tozorakimabAstraZenecaChronic Obstructive Pulmonary DiseasePhase 3NCT07566195
2028-12-30BevacizumabRocheNon-Small Cell Lung CancerPhase 3NCT07058428
2028-12-30EverolimusNovartisRenal Cell CarcinomaPhase 3NCT07165418
2028-12-30FruquintinibHUTCHMED, Takeda Pharmaceutical CompanyColorectal Cancer, Metastatic Colorectal Cancer, Advanced Metastatic Colorectal CancerPhase 3NCT07362836
2028-12-30HSK44459Haisco Pharmaceutical GroupProgressive Pulmonary FibrosisPhase 3NCT07503587
2028-12-30PyrotinibDr. Reddy's Laboratories, HLB Life Science, Jiangsu Hengrui PharmaceuticalsHER2-Positive Breast CancerPhase 3NCT07615751
2028-12-30ZoldonrasibRevolution MedicinesPancreatic CancerPhase 3NCT07621718
2028-12-30Iparomlimab and tuvonralimabQilu PharmaceuticalSmall Cell Lung CancerPhase 2/3NCT07636226
2028-12-30Bevacizumab, Iparomlimab and tuvonralimabRoche, Qilu PharmaceuticalColorectal CancerPhase 3NCT07729605
2028-12-30FudotinibGuangzhou JOYO PharmaNon-Small Cell Lung CancerPhase 3NCT07816380
2028-12-30Bevacizumab, Ruzaltatug rezetecanRoche, Jiangsu Hengrui PharmaceuticalsNon-Small Cell Lung CancerPhase 3NCT07895992
2028-12-31Lorazepam, HaloperidolHikma Pharmaceuticals PLC, Johnson & JohnsonDelirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant NeoplasmPhase 2/3NCT03743649
2028-12-31Durvalumab, pemetrexedAstraZeneca, Eli LillyNon-Small Cell Lung CancerPhase 3NCT04092283
2028-12-31ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceNK/T Cell Lymphoma NosPhase 3NCT04365036
2028-12-31DexamethasoneAVB - Atrioventricular Block, Fetal AVBPhase 3NCT04474223
2028-12-31CamrelizumabElevar Therapeutics, Inc., Jiangsu Hengrui PharmaceuticalsResectable Esophageal Squamous Cell CarcinomaPhase 3NCT05043688
2028-12-31TemozolomideMerck & Co.GlioblastomaPhase 3NCT05439278
2028-12-31HydroxychloroquineAdvanz PharmaSystemic Lupus ErythematosusPhase 3NCT05799378
2028-12-31IvonescimabAkeso, Summit TherapeuticsNon-Small Cell Lung CancerPhase 3NCT05899608
2028-12-31Ifupinostat, RituximabBeBetter Med, Biogen, Chugai PharmaRelapsed/Refractory Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell LymphomaPhase 3NCT06792253
2028-12-31afimkibartPfizer, RocheCrohn's DiseasePhase 3NCT06819878
2028-12-31afimkibartPfizer, RocheCrohn's DiseasePhase 3NCT06819891
2028-12-31CadonilimabAkesoRectal CancerPhase 3NCT06832917
2028-12-31Camrelizumab, Apatinib, Eribulin mesylateElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Advenchen LaboratoriesBreast CancerPhase 3NCT06889688
2028-12-31Osimertinib, GlumetinibAstraZeneca, Haihe Biopharma, Taiho PharmaceuticalNon-Small Cell Lung CancerPhase 2/3NCT06908772
2028-12-31CadonilimabAkesoGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Neoadjuvant Therapy, Adjuvant Chemotherapy, pCR Rate, MPR, ORR,OS,PFSPhase 3NCT06949033
2028-12-31brepocitinibPfizer, Roivant Sciences Ltd.Cutaneous SarcoidosisPhase 2/3NCT06978725
2028-12-31IvonescimabAkeso, Summit TherapeuticsSmall Cell Lung CancerPhase 3NCT07010263
2028-12-31MasitinibAB ScienceAmyotrophic Lateral SclerosisPhase 3NCT07174492
2028-12-31OcankitugKeymed Biosciences, Shanghai JMT-BioAsthmaPhase 3NCT07372287
2028-12-31Famitinib, Trastuzumab rezetecanJiangsu Hengrui Pharmaceuticals, Glenmark Pharmaceuticals Ltd.HR+/HER2- Metastatic Breast Cancer, Breast CancerPhase 3NCT07382687
2028-12-31CPO301Conjupro Biotherapeutics, Inc.Locally Advanced/Metastatic/Recurrent ESCCPhase 3NCT07417735
2028-12-31Risvutatug rezetecanGlaxoSmithKline, Hansoh Pharmaceutical GroupNon-Small Cell Lung CancerPhase 3NCT07464327
2028-12-31brepocitinibPfizer, Roivant Sciences Ltd.Lichen PlanopilarisPhase 2/3NCT07532603
2028-12-31Camrelizumab, ApatinibElevar Therapeutics, Inc., Jiangsu Hengrui Pharmaceuticals, Advenchen LaboratoriesHCCPhase 2/3NCT07589244
2028-12-31Ruxolitinib (Opzelura)Incyte, MaruhoVitiligoPhase 3NCT07595939
2028-12-31Retlirafusp alfa, CapecitabineJiangsu Hengrui Pharmaceuticals, Cheplapharm Arzneimittel GmbHGastric CancerPhase 3NCT07677293
2028-12-31IsatuximabSanofiMultiple MyelomaPhase 2/3NCT07732712
2028-12-31IvonescimabAkeso, Summit TherapeuticsBiliary Tract CancerPhase 2/3NCT07765433
2028-12-31PembrolizumabMerck & Co.Resectable Liposarcoma, Resectable Soft Tissue Sarcoma, Resectable Undifferentiated Pleomorphic SarcomaPhase 3NCT07823491
2028-12-31NusinersenBiogen, Ionis PharmaceuticalsSpinal Muscular AtrophyPhase 3NCT07846696
2028-12-31ToripalimabCoherus BioSciences, Inc., Shanghai Junshi BioscienceRectal CancerPhase 2/3NCT07935759

Source: ClinicalTrials.gov, each study's record, checked daily. Studies that are terminated, withdrawn or completed are left out, as are programmes their developer has stopped. A month-only date is shown as given.